Article
A CRISPR/Cas9 based strategy to manipulate the Alzheimer’s amyloid pathway
2018-04-28
Abstract excerpt
The gradual accumulation of amyloid-β (Aβ) is a neuropathologic hallmark of Alzheimer’s disease (AD); playing a key role in disease progression. Aβ is generated by the sequential cleavage of amyloid precursor protein (APP) by β- and γ-secretases, with BACE-1 (β-site APP cleaving enzyme-1) cleavage as the rate limiting step 1–3 . CRISPR/Cas9 guided gene-editing is emerging as a promising tool to edit pathogenic mu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 22c7ccb6-ead4-5f4d-9018-bfbfc43314c7
- DOI
- 10.1101/310193
